Sex-Specific Alterations in Dopamine Metabolism in the Brain after Methamphetamine Self-Administration

International Journal of Molecular Sciences

卷:23

David S. Goldstein¹  Patricia Sullivan¹  Jean Lud Cadet²  Subramaniam Jayanthi²  Atul P. Daiwile² 

[1] Autonomic Medicine Section, NINDS Intramural Research Program, National Institutes of Health (NIH), Bethesda, MD 20892, USA;

[2] Molecular Neuropsychiatry Research Branch, NIDA Intramural Research Program, National Institutes of Health (NIH), Baltimore, MD 21224, USA;

关键词: methamphetamine;    sex differences;    dopamine;    DA metabolites;    mesocorticolimbic;   

DOI  :  10.3390/ijms23084353

来源: DOAJ

【 摘 要 】

Methamphetamine (METH) use disorder affects both sexes, with sex differences occurring in behavioral, structural, and biochemical consequences. The molecular mechanisms underlying these differences are unclear. Herein, we used a rat model to identify potential sex differences in the effects of METH on brain dopaminergic systems. Rats were trained to self-administer METH for 20 days, and a cue-induced drug-seeking test was performed on withdrawal days 3 and 30. Dopamine and its metabolites were measured in the prefrontal cortex (PFC), nucleus accumbens (NAc), dorsal striatum (dSTR), and hippocampus (HIP). Irrespective of conditions, in comparison to females, male rats showed increased 3,4-dihydroxyphenylalanine (DOPA) in the PFC, dSTR, and HIP; increased cys-dopamine in NAc; and increased 3,4-dihydroxyphenylethanol (DOPET) and 3,4-dihydroxyphenylacetic acid (DOPAC) in dSTR. Males also showed METH-associated decreases in DA levels in the HIP but increases in the NAc. Female rats showed METH-associated decreases in DA, DOPAL, and DOPAC levels in the PFC but increases in DOPET and DOPAC levels in the HIP. Both sexes showed METH-associated decreases in NAc DA metabolites. Together, these data document sex differences in METH SA-induced changes in DA metabolism. These observations provide further support for using sex as an essential variable when discussing therapeutic approaches against METH use disorder in humans.

【 授权许可】

Unknown